Ardelyx’s $20 Million Agreement with HealthCare Royalty Partners

Latham & Watkins represented Ardelyx, Inc. in the transaction in the transaction.Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and…

This content is for members only.
Login to Read More Join Now
Laura Testa

Author: Laura Testa

This content is for members only.
Login to Read More Join Now